Gastric peroral endoscopic myotomy versus botulinum toxin injection for the treatment of refractory gastroparesis: results of a double-blind randomized controlled study

 

 Buy Article Permissions and Reprints

Abstract

Introduction Gastric peroral endoscopic myotomy (G-POEM) is a promising technique for treating refractory gastroparesis. We present the first double-blind randomized study comparing the clinical efficacy of G-POEM versus pyloric botulinum toxin injection (BTI).

Methods This randomized study, conducted in two expert centers, enrolled patients with refractory gastroparesis, medically managed for >6 months and confirmed by gastric emptying scintigraphy (GES), into two groups, G-POEM versus BTI, with follow-up of 1 year. The primary end point was the 3-month clinical efficacy, defined as a >1-point decrease in the mean Gastroparesis Cardinal Symptom Index (GCSI) score. Secondary end points were: 1-year efficacy, GES evolution, adverse events, and quality of life.

Results 40 patients (22 women; mean age 48.1 [SD 17.4]), with mean symptom duration of 5.8 (SD 5.7) years, were randomized. Etiologies included idiopathic (n=18), diabetes (n=11), postoperative (n=6), and mixed (n=4). G-POEM showed a higher 3-month clinical success than BTI (65% vs. 40%, respectively; P=0.10), along with non-significantly higher 1-year clinical success (60% vs. 40%, respectively) on intention-to-treat analysis. The GCSI decreased in both groups at 3 months and 1 year. Only three minor adverse events occurred in the G-POEM group. The GES improvement rate was 72% in the G-POEM group versus 50% in the BTI group (non-significant).

Conclusion G-POEM seems to have a higher clinically relevant success rate than BTI, but this was not statistically demonstrated. This study confirms the interest in treatments targeting the pylorus, either mechanically or chemically, for managing refractory gastroparesis.

Publication History

Received: 05 April 2023

Accepted after revision: 23 December 2023

Accepted Manuscript online:
23 December 2023

Article published online:
19 February 2024

© 2024. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

• References

• 1 Schol J, Wauters L, Dickman R. et al. United European Gastroenterology (UEG) and European Society for Neurogastroenterology and Motility (ESNM) consensus on gastroparesis. Neurogastroenterol Motil 2021; 33: 287-306 DOI: 10.1002/ueg2.12060. (PMID: 33939892)
  CrossrefPubMedGoogle Scholar
• 2 Jung HK, Choung RS, Locke GR. et al. The incidence, prevalence, and outcomes of patients with gastroparesis in Olmsted County, Minnesota, from 1996 to 2006. Gastroenterology 2009; 136: 1225-1233
  CrossrefPubMedGoogle Scholar
• 3 Wadhwa V, Mehta D, Jobanputra Y. et al. Healthcare utilization and costs associated with Gastroparesis. World J Gastroenterol 2017; 23: 4428-4436
  CrossrefPubMedGoogle Scholar
• 4 Ye Y, Jiang B, Manne S. et al. Epidemiology and outcomes of gastroparesis, as documented in general practice records, in the United Kingdom. Gut 2021; 70: 644-653 DOI: 10.1136/gutjnl-2020-321277. (PMID: 32493829)
  CrossrefPubMedGoogle Scholar
• 5 Cassilly DW, Wang YR, Friedenberg FK. et al. Symptoms of gastroparesis: use of the gastroparesis cardinal symptom index in symptomatic patients referred for gastric emptying scintigraphy. Digestion 2008; 78: 144-151 DOI: 10.1159/000175836. (PMID: 19033686)
  CrossrefPubMedGoogle Scholar
• 6 Revicki DA, Rentz AM, Dubois D. et al. Development and validation of a patient-assessed gastroparesis symptom severity measure: the Gastroparesis Cardinal Symptom Index. Aliment Pharmacol Ther 2003; 18: 141-150 DOI: 10.1046/j.1365-2036.2003.01612.x. (PMID: 12848636)
  CrossrefPubMedGoogle Scholar
• 7 Arts J, Holvoet L, Caenepeel P. et al. Clinical trial: a randomized-controlled crossover study of intrapyloric injection of botulinum toxin in gastroparesis. Aliment Pharmacol Ther 2007; 26: 1251-1258 DOI: 10.1111/j.1365-2036.2007.03467.x. (PMID: 17944739)
  CrossrefPubMedGoogle Scholar
• 8 Camilleri M, Bharucha AE, Farrugia G. Epidemiology, mechanisms, and management of diabetic gastroparesis. Clin Gastroenterol Hepatol 2011; 9: 5-12 DOI: 10.1016/j.cgh.2010.09.022. (PMID: 20951838)
  CrossrefPubMedGoogle Scholar
• 9 Lal N, Livemore S, Dunne D. et al. Gastric electrical stimulation with the Enterra System: a systematic review. Gastroenterol Res Pract 2015; 2015: 762972
  PubMedGoogle Scholar
• 10 Hasler WL. Methods of gastric electrical stimulation and pacing: a review of their benefits and mechanisms of action in gastroparesis and obesity. Neurogastroenterol Motil 2009; 21: 229-243 DOI: 10.1111/j.1365-2982.2009.01277.x. (PMID: 19254353)
  CrossrefPubMedGoogle Scholar
• 11 Levinthal DJ, Bielefeldt K. Systematic review and meta-analysis: Gastric electrical stimulation for gastroparesis. Auton Neurosci 2017; 202: 45-55 DOI: 10.1016/j.autneu.2016.03.004. (PMID: 27085627)
  CrossrefPubMedGoogle Scholar
• 12 Mearin F, Camilleri M, Malagelada JR. Pyloric dysfunction in diabetics with recurrent nausea and vomiting. Gastroenterology 1986; 90: 1919-1925 DOI: 10.1016/0016-5085(86)90262-3. (PMID: 3699409)
  CrossrefPubMedGoogle Scholar
• 13 Nguyen LA, Snape WJ. Clinical presentation and pathophysiology of gastroparesis. Gastroenterol Clin North Am 2015; 44: 21-30 DOI: 10.1016/j.gtc.2014.11.003. (PMID: 25667020)
  CrossrefPubMedGoogle Scholar
• 14 Parkman HP, Pasricha PJ. Improving our understanding of gastroparesis. Gastroenterol Clin North Am 2015; 44: xv-xvi DOI: 10.1016/j.gtc.2014.12.001. (PMID: 25667034)
  CrossrefPubMedGoogle Scholar
• 15 Friedenberg FK, Palit A, Parkman HP. et al. Botulinum toxin A for the treatment of delayed gastric emptying. Am J Gastroenterol 2008; 103: 416-423 DOI: 10.1111/j.1572-0241.2007.01676.x. (PMID: 18070232)
  CrossrefPubMedGoogle Scholar
• 16 Ukleja A, Tandon K, Shah K. et al. Endoscopic botox injections in therapy of refractory gastroparesis. World J Gastrointest Endosc 2015; 7: 790-798 DOI: 10.4253/wjge.v7.i8.790. (PMID: 26191343)
  CrossrefPubMedGoogle Scholar
• 17 Bromer MQ, Friedenberg F, Miller LS. et al. Endoscopic pyloric injection of botulinum toxin A for the treatment of refractory gastroparesis. Gastrointest Endosc 2005; 61: 833-839 DOI: 10.1016/s0016-5107(05)00328-7. (PMID: 15933684)
  CrossrefPubMedGoogle Scholar
• 18 Weusten BLAM, Barret M, Bredenoord AJ. et al. Endoscopic management of gastrointestinal motility disorders – Part 1: European Society of Gastrointestinal Endoscopy (ESGE) Guideline. Endoscopy 2020; 52: 498-515
  Article in Thieme ConnectPubMedGoogle Scholar
• 19 Shlomovitz E, Pescarus R, Cassera MA. et al. Early human experience with per-oral endoscopic pyloromyotomy (POP). Surg Endosc 2015; 29: 543-551
  CrossrefPubMedGoogle Scholar
• 20 Chaves DM, de Moura EGH, Mestieri LHM. et al. Endoscopic pyloromyotomy via a gastric submucosal tunnel dissection for the treatment of gastroparesis after surgical vagal lesion. Gastrointest Endosc 2014; 80: 164 DOI: 10.1016/j.gie.2014.03.045. (PMID: 24836745)
  CrossrefPubMedGoogle Scholar
• 21 Khashab MA, Besharati S, Ngamruengphong S. et al. Refractory gastroparesis can be successfully managed with endoscopic transpyloric stent placement and fixation (with video). Gastrointest Endosc 2015; 82: 1106-1109
  CrossrefPubMedGoogle Scholar
• 22 Gonzalez JM, Benezech A, Vitton V. et al. G-POEM with antro-pyloromyotomy for the treatment of refractory gastroparesis: mid-term follow-up and factors predicting outcome. Aliment Pharmacol Ther 2017; 46: 364-370
  CrossrefPubMedGoogle Scholar
• 23 Kahaleh M, Gonzalez J-M, Xu M-M. et al. Gastric peroral endoscopic myotomy for the treatment of refractory gastroparesis: a multicenter international experience. Endoscopy 2018; 50: 1053-1058 DOI: 10.1055/a-0596-7199. (PMID: 29649841)
  Article in Thieme ConnectPubMedGoogle Scholar
• 24 Mekaroonkamol P, Shah R, Cai Q. Outcomes of per oral endoscopic pyloromyotomy in gastroparesis worldwide. World J Gastroenterol 2019; 25: 909-922 DOI: 10.3748/wjg.v25.i8.909. (PMID: 30833798)
  CrossrefPubMedGoogle Scholar
• 25 Ragi O, Jacques J, Branche J. et al. One-year results of gastric peroral endoscopic myotomy for refractory gastroparesis: A French multicenter study. Endoscopy 2021; 53: 480-490 DOI: 10.1055/a-1205-5686. (PMID: 32575130)
  Article in Thieme ConnectPubMedGoogle Scholar
• 26 Yan J, Tan Y, Zhou B. et al. Gastric per-oral endoscopic myotomy (G-POEM) is a promising treatment for refractory gastroparesis: a systematic review and meta-analysis. Rev Esp Enferm Dig 2020; 112: 219-228 DOI: 10.17235/reed.2020.6559/2019. (PMID: 32081015)
  CrossrefPubMedGoogle Scholar
• 27 Aghaie Meybodi M, Qumseya B, Shakoor D. et al. Efficacy and feasibility of G-POEM in management of patients with refractory gastroparesis: a systematic review and meta-analysis. Endosc Int Open 2019; 07: E322-E329
  Article in Thieme ConnectPubMedGoogle Scholar
• 28 Vosoughi K, Ichkhanian Y, Benias P. et al. Gastric per-oral endoscopic myotomy (G-POEM) for refractory gastroparesis: results from an international prospective trial. Gut 2022; 71: 25-33
  CrossrefPubMedGoogle Scholar
• 29 Martinek J, Hustak R, Mares J. et al. Endoscopic pyloromyotomy for the treatment of severe and refractory gastroparesis: a pilot, randomised, sham-controlled trial. Gut 2022; 71: 2170-2178 DOI: 10.1136/gutjnl-2022-326904. (PMID: 35470243)
  CrossrefPubMedGoogle Scholar
• 30 Abell TL, Camilleri M, Donohoe K. et al. Consensus recommendations for gastric emptying scintigraphy: a joint report of the American Neurogastroenterology and Motility Society and the Society of Nuclear Medicine. J Nucl Med Technol 2008; 36: 44-54 DOI: 10.1111/j.1572-0241.2007.01636.x. (PMID: 18028513)
  CrossrefPubMedGoogle Scholar
• 31 Vosoughi K, Ichkhanian Y, Benias P. et al. Gastric per-oral endoscopic myotomy (G-POEM) for refractory gastroparesis: results from an international prospective trial. Gut 2022; 71: 25-33
  CrossrefPubMedGoogle Scholar
• 32 DiBaise JK, Patel N, Noelting J. et al. The relationship among gastroparetic symptoms, quality of life, and gastric emptying in patients referred for gastric emptying testing. Neurogastroenterol Motil 2016; 28: 234-242
  CrossrefPubMedGoogle Scholar
• 33 Parkman HP, Hallinan EK, Hasler WL. et al. Early satiety and postprandial fullness in gastroparesis correlate with gastroparesis severity, gastric emptying, and water load testing. Neurogastroenterol Motil 2017; 29 DOI: 10.1111/nmo.12981.
  CrossrefPubMedGoogle Scholar
• 34 McCallum RW, Snape W, Brody F. et al. Gastric electrical stimulation with Enterra therapy improves symptoms from diabetic gastroparesis in a prospective study. Clin Gastroenterol Hepatol 2010; 8: 947-954
  CrossrefPubMedGoogle Scholar
• 35 Rodriguez J, Strong AT, Haskins IN. et al. Per-oral pyloromyotomy (POP) for medically refractory gastroparesis. Ann Surg 2018; 268: 421-430 DOI: 10.1097/SLA.0000000000002927. (PMID: 30004920)
  CrossrefPubMedGoogle Scholar
• 36 Gonzalez J, Lestelle V, Benezech A. et al. Gastric per-oral endoscopic myotomy with antro-pyloro-myotomy in the treatment of refractory gastroparesis: clinical experience with follow-up and scintigraphic evaluation (with video). Gastrointest Endosc 2017; 85: 132-139
  CrossrefPubMedGoogle Scholar
• 37 Spadaccini M, Maselli R, Chandrasekar VT. et al. Gastric peroral endoscopic pyloromyotomy for refractory gastroparesis: a systematic review of early outcomes with pooled analysis. Gastrointest Endosc 2020; 91: 746-752.e5
  CrossrefPubMedGoogle Scholar
• 38 Thomas A, de Souza Ribeiro B, Malespin M. et al. Botulinum toxin as a treatment for refractory gastroparesis: a literature review. Curr Treat Options Gastroenterol 2018; 16: 479-488
  CrossrefPubMedGoogle Scholar
• 39 Camilleri M, Brown ML, Malagelada JR. Relationship between impaired gastric emptying and abnormal gastrointestinal motility. Gastroenterology 1986; 91: 94-99 DOI: 10.1016/0016-5085(86)90444-0. (PMID: 3710086)
  CrossrefPubMedGoogle Scholar

• Supplementary Material